Angiotensin II (ANG II) is known to be a potent growth promoting factor for vascular smooth muscle cells and fibroblasts but little is known about its influence on growth in endothelial cells. We studied the effects of ANG II on endothelial growth and the role of the angiotensin receptor subtypes involved. Proliferation of rat coronary endothelial cells (CEC) and rat vascular smooth muscle cells (VSMC) was determined by [3H]thymidine incorporation, the MTT-test and by directly counting cells in a coulter counter. Angiotensin AT1- and AT2-receptors were demonstrated by binding studies and by the presence of their respective mRNA through reverse transcription polymerase chain reaction (RT-PCR). In contrast to VSMC, which in culture only express the AT1-receptor, CEC express both, AT1- and AT2-receptors simultaneously up to the third passage. Whereas ANG II stimulated growth of quiescent VSMC, an effect abolished by pretreatment with the AT1-receptor antagonist, losartan, ANG II did not induce proliferation in quiescent CEC. However, after pretreatment of quiescent endothelial cells (< passage 4) with the AT2-receptor antagonist, PD 123177, ANG II induced proliferation. This effect was reversed by additional pretreatment with losartan. ANG II significantly inhibited the proliferation of bFGF-stimulated CEC in a dose-dependent manner by maximally 50%. This effect was prevented by PD 123177 while losartan was ineffective. The AT2-receptor agonist, CGP 42112, mimicked the antiproliferative actions of ANG II, confirming the specificity of the effect. Our results show that the growth modulating actions of ANG II depend on the type of angiotensin receptor present on a given cell. In coronary endothelial cells, the antiproliferative actions of the AT2-receptor offset the growth promoting effects mediated by the AT1-receptor.
M Stoll, U M Steckelings, M Paul, S P Bottari, R Metzger, T Unger
Title and authors | Publication | Year |
---|---|---|
Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth
M Akishita, M Ito, JY Lehtonen, L Daviet, VJ Dzau, M Horiuchi |
Journal of Clinical Investigation | 1999 |
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation
Y Tsutsumi, H Matsubara, H Masaki, H Kurihara, S Murasawa, S Takai, M Miyazaki, Y Nozawa, R Ozono, K Nakagawa, T Miwa, N Kawada, Y Mori, Y Shibasaki, Y Tanaka, S Fujiyama, Y Koyama, A Fujiyama, H Takahashi, T Iwasaka |
Journal of Clinical Investigation | 1999 |
The Renin-Angiotensin System and Its Receptors
U Stroth, T Unger |
Journal of Cardiovascular Pharmacology | 1999 |
Mechanism of action of angiotensin-receptor blocking agents
HM Siragy, M Bedigian |
Current Hypertension Reports | 1999 |
Effects of a novel angiotensin AT1 receptor antagonist, HR720, on rats with myocardial infarction
QG Xia, O Chung, H Spitznagel, S Sandmann, S Illner, B Rossius, G Jähnichen, A Reinecke, P Gohlke, T Unger |
European Journal of Pharmacology | 1999 |
Björn Fokow Award Lecture The angiotensin type 2 receptor
T Unger |
Journal of Hypertension | 1999 |
Novel actions of angiotensin II via its renal type-2 (AT2) receptor
RM Carey, ZQ Wang, HM Siragy |
Current Hypertension Reports | 1999 |
Early captopril prevents myocardial infarction-induced hypertrophy but not angiogenesis
EA Kalkman, P Haren, PR Saxena, RG Schoemaker |
European Journal of Pharmacology | 1999 |
Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells
PD Paolisa, A Porcellini, B Gigante, R Giliberti, A Lombardi, C Savoia, S Rubattu, M Volpe |
Journal of Hypertension | 1999 |
No vasoactive role of the angiotensin II type 2 receptor in normotensive Wistar rats
MP Schuijt, R Vries, PR Saxena, AH Danser |
Journal of Hypertension | 1999 |
Angiotensin II type 1 and type 2 receptors bind angiotensin II through different types of epitope recognition
S Miura, SS Karnik |
Journal of Hypertension | 1999 |
Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension
WH Birkenhäger, PW de Leeuw |
Journal of Hypertension | 1999 |
Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblasts
M Tamura, YJ Chen, EF Howard, M Tanner, EJ Landon, PR Myers |
European Journal of Pharmacology | 1999 |
Signaling Mechanism of the AT2 Angiotensin II Receptor: Crosstalk between AT1 and AT2 Receptors in Cell Growth
M Horiuchi, JY Lehtonen, L Daviet |
Trends in Endocrinology & Metabolism | 1999 |
Selective Potentiation of Angiotensin-Induced Constriction of Skeletal Muscle Resistance Arteries by Chronic Elevations in Dietary Salt Intake
DS Weber, JC Frisbee, JH Lombard |
Microvascular Research | 1999 |
Angiotensin II and extracellular matrix homeostasis
KT Weber, SK Swamynathan, RV Guntaka, Y Sun |
The International Journal of Biochemistry & Cell Biology | 1999 |
The Localization and Expression of the Renin–angiotensin System in the Human Placenta Throughout Pregnancy
AC Cooper, G Robinson, GP Vinson, WT Cheung, FB Pipkin |
Placenta | 1999 |
Increased Vasoconstrictor Response of the Mouse Lacking Angiotensin II Type 2 Receptor
M Akishita, H Yamada, VJ Dzau, M Horiuchi |
Biochemical and Biophysical Research Communications | 1999 |
Vascular Response to Angiotensin II Is Exaggerated through an Upregulation of AT1 Receptor in AT2 Knockout Mice
M Tanaka, S Tsuchida, T Imai, N Fujii, H Miyazaki, T Ichiki, M Naruse, T Inagami |
Biochemical and Biophysical Research Communications | 1999 |
Angiotensin II and nitric oxide: a question of balance
LJ Millatt, EM Abdel-Rahman, HM Siragy |
Regulatory Peptides | 1999 |
The AT2 receptor: fact, fancy and fantasy
M Gasparo, HM Siragy |
Regulatory Peptides | 1999 |
Angiotensin II and connective tissue: homeostasis and reciprocal regulation
KT Weber |
Regulatory Peptides | 1999 |
Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells:
PD Paolisa, A Porcellini, B Gigante, R Giliberti, A Lombardi, C Savoia, S Rubattu, M Volpe |
Journal of Hypertension | 1999 |
Pharmacology of eprosartan, an angiotensin II receptor antagonist: Exploring hypotheses from clinical data
DP Brooks, EH Ohlstein, RR Ruffolo |
American Heart Journal | 1999 |
AT2 receptor stimulation induces generation of ceramides in PC12W cells
S Gallinat, S Busche, S Schütze, M Krönke, T Unger |
FEBS Letters | 1999 |
An A/T-rich cis-element is essential for rat angiotensin II type 1A receptor transcription in vascular smooth muscle cells
KB Beason, CG Acuff, ME Steinhelper, TS Elton |
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression | 1999 |
Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and disease
BH Lorell |
The American Journal of Cardiology | 1999 |
Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk
M Horiuchi, W Hayashida, M Akishita, K Tamura, L Daviet, JY Lehtonen, VJ Dzau |
Circulation research | 1999 |
Involvement of the angiotensin II type 2 receptor in apoptosis during human fetal adrenal gland development
E Chamoux, L Breault, JG Lehoux, N Gallo-Payet |
The Journal of clinical endocrinology and metabolism | 1999 |
Practical Considerations of the Pharmacology of Angiotensin Receptor Blockers
MM McConnaughey, JS McConnaughey, AJ Ingenito |
The Journal of Clinical Pharmacology | 1999 |
Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation
DY Li, YC Zhang, MI Philips, T Sawamura, JL Mehta |
Circulation research | 1999 |
Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy
Z Cao, R Dean, L Wu, D Casley, ME Cooper |
Hypertension | 1999 |
Recent progress in angiotensin II type 2 receptor research in the cardiovascular system
M Horiuchi, M Akishita, VJ Dzau |
Hypertension | 1999 |
Opposing actions of angiotensins on angiogenesis
RD Machado, RA Santos, SP Andrade |
Life Sciences | 1999 |
Role of the His273 Located in the Sixth Transmembrane Domain of the Angiotensin II Receptor Subtype AT2 in Ligand–Receptor Interaction
CA Turner, S Cooper, L Pulakat |
Biochemical and Biophysical Research Communications | 1999 |
Adding losartan to lisinopril therapy in patients with hypertension: Assessment by 24-hour ambulatory blood pressure monitoring
R Fogari, A Zoppi, L Corradi, L Poletti, E Piazza, A Mugellini, EB Pilun, P Preti |
Current Therapeutic Research | 1999 |
Role of Arg182 in the Second Extracellular Loop of Angiotensin II Receptor AT2 in Ligand Binding
J Kurfis, D Knowle, L Pulakat |
Biochemical and Biophysical Research Communications | 1999 |
Actions of endothelin-1 on cultured rat renomedullary interstitial cells are modulated by nitric oxide
C Maric, G P Aldred, A M Antoine, E Eitle, R G Dean, D A Williams, P J Harris, D Alcorn |
Clinical and experimental pharmacology & physiology | 1999 |
Role of AT 1 receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice
TJ Bivalacqua, A Dalal, HC Champion, PJ Kadowitz |
American journal of physiology. Endocrinology and metabolism | 1999 |
Renal cellular response to ureteral obstruction: role of maturation and angiotensin II
RL Chevalier, BA Thornhill, JT Wolstenholme |
American journal of physiology. Renal physiology | 1999 |
Effect of AT 2 receptor blockade on the pathogenesis of renal fibrosis
JJ Morrissey, S Klahr |
American journal of physiology. Renal physiology | 1999 |
Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of AT 1 receptor and PKC activation
D Li, B Yang, MI Philips, JL Mehta |
American journal of physiology. Heart and circulatory physiology | 1999 |
Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction
GE Sander, JJ McKinnie, SS Greenberg, TD Giles |
Progress in Cardiovascular Diseases | 1999 |
Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT 1 receptors
NW Morrell, PD Upton, S Kotecha, A Huntley, MH Yacoub, JM Polak, J Wharton |
American journal of physiology. Lung cellular and molecular physiology | 1999 |
Activation of the AT 2 Receptor of Angiotensin II Induces Neurite Outgrowth and Cell Migration in Microexplant Cultures of the Cerebellum
F Côté, TH Do, L Laflamme, JM Gallo, N Gallo-Payet |
The Journal of biological chemistry | 1999 |
Activation of the de novo Biosynthesis of Sphingolipids Mediates Angiotensin II Type 2 Receptor-induced Apoptosis
JY Lehtonen, M Horiuchi, L Daviet, M Akishita, VJ Dzau |
The Journal of biological chemistry | 1999 |
Regulation of Sarcolemmal Na+/H+ Exchanger Activity by Angiotensin II in Adult Rat Ventricular Myocytes : Opposing Actions via AT1 Versus AT2 Receptors
S Gunasegaram, RS Haworth, DJ Hearse, M Avkiran |
Circulation research | 1999 |
Differential Regulation of Renal Angiotensin Subtype AT 1A and AT 2 Receptor Protein in Rats With Angiotensin-Dependent Hypertension
ZQ Wang, LJ Millatt, NT Heiderstadt, HM Siragy, RA Johns, RM Carey |
Hypertension | 1999 |
Mechanical Stretch and Angiotensin II Differentially Upregulate the Renin-Angiotensin System in Cardiac Myocytes In Vitro
R Malhotra, J Sadoshima, FC Brosius, S Izumo |
Circulation research | 1999 |
Role of AT 2 Receptors in Angiotensin II–Stimulated Contraction of Small Mesenteric Arteries in Young SHR
RM Touyz, D Endemann, G He, JS Li, EL Schiffrin |
Hypertension | 1999 |
AT 2 Receptor Stimulation Enhances Antihypertensive Effect of AT 1 Receptor Antagonist in Hypertensive Rats
MN Barber, DB Sampey, RE Widdop |
Hypertension | 1999 |
Angiotensin II Type 2 Receptor Blockade Amplifies the Early Signals of Cardiac Growth Response to Angiotensin II in Hypertrophied Hearts
J Bartunek, EO Weinberg, M Tajima, S Rohrbach, BH Lorell |
Circulation | 1999 |
Antiproliferative Actions of Angiotensin-(1-7) in Vascular Smooth Muscle
EA Tallant, DI Diz, CM Ferrario |
Hypertension | 1999 |
AT 2 Receptor and Vascular Smooth Muscle Cell Differentiation in Vascular Development
H Yamada, M Akishita, M Ito, K Tamura, L Daviet, JY Lehtonen, VJ Dzau, M Horiuchi |
Hypertension | 1999 |
Angiotensin II Stimulates Intercellular Adhesion Molecule-1 (ICAM-1) Expression by Human Vascular Endothelial Cells and Increases Soluble ICAM-1 Release In Vivo
L Pastore, A Tessitore, S Martinotti, E Toniato, E Alesse, MC Bravi, C Ferri, G Desideri, A Gulino, A Santucci |
Circulation | 1999 |
Intracellular Sodium Modulates the Expression of Angiotensin II Subtype 2 Receptor in PC12W Cells
M Tamura, Y Wanaka, EJ Landon, T Inagami |
Hypertension | 1999 |
Angiotensin II Stimulates Collagen Synthesis in Human Vascular Smooth Muscle Cells: Involvement of the AT 1 Receptor, Transforming Growth Factor-β, and Tyrosine Phosphorylation
CM Ford, S Li, JG Pickering |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Effects of Candesartan and Cilazapril on Rats With Myocardial Infarction Assessed by Echocardiography
M Yoshiyama, K Takeuchi, T Omura, S Kim, H Yamagishi, I Toda, M Teragaki, K Akioka, H Iwao, J Yoshikawa |
Hypertension | 1999 |
Role of Angiotensin Receptor Blockers in Heart Failure: Not Yet RESOLVD
BH Greenberg |
Circulation | 1999 |
In Vivo Study of AT 1 and AT 2 Angiotensin Receptors in Apoptosis in Rat Blood Vessels
QN Diep, JS Li, EL Schiffrin |
Hypertension | 1999 |
Analysis of Functional Domains of Angiotensin II Type 2 Receptor Involved in Apoptosis
JY Lehtonen, L Daviet, C Nahmias, M Horiuchi, VJ Dzau |
Molecular Endocrinology | 1999 |
Angiotensin II Type 2 Receptor-Mediated Apoptosis of Cultured Neurons from Newborn Rat Brain**This work was supported by a grant from the NIH (NS-19441) and a postdoctoral fellowship (to U.V.S.) from the American Heart Association, Florida Affiliate
UV Shenoy, EM Richards, XC Huang, C Sumners |
Endocrinology | 1999 |
AT1-Rezeptorblockade
P Dominiak, G Heusch |
1999 | |
Molecular Cardiology in Clinical Practice
M Sanders, JB Kostis |
1999 | |
Hormones and the Heart in Health and Disease
L Share |
1999 | |
Angiotensin II AT1-Rezeptorantagonisten
P Dominiak, T Unger |
1999 | |
Signals from the AT2 (Angiotensin Type 2) Receptor of Angiotensin II Inhibit p21ras and Activate MAPK (Mitogen-Activated Protein Kinase) to Induce Morphological Neuronal Differentiation in NG108–15 Cells
L Gendron, L Laflamme, N Rivard, C Asselin, MD Payet, N Gallo-Payet |
Molecular Endocrinology | 1999 |
Comparative Safety and Tolerability of Angiotensin II Receptor Antagonists:
L Mazzolai, M Burnier |
Drug Safety | 1999 |
Characterization of AT2 receptor expression in NIH 3T3 fibroblasts
F M Heemskerk, S Zorad, N Xu, S J Gutkind, J M Saavedra |
Cellular and Molecular Neurobiology | 1999 |